by admin | Jul 16, 2024 | News
Gifford Bioscience contributes its receptor pharmacology expertise to the study of the effect of methylone as a rapid-acting neuroplastogen, with greater specificity than MDMA. This bolsters methylone’s potential use in the treatment of PTSD and other... by admin | Jul 2, 2024 | Testimonials
87% of our business is repeat business, working with the scientists we have collaborated with before.
Recent Comments